The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Autoimmune Hypophysitis

Rare disease characterized by autoimmune-mediated inflammation of the pituitary gland.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is Autoimmune Hypophysitis?

Autoimmune hypophysitis is rare inflammation of the pituitary gland and/or pituitary stalk by autoimmune mechanism, presenting with hormone deficiency, mass effect or both.

Subtypes include lymphocytic hypophysitis (most common, classically peripartum), granulomatous hypophysitis, IgG4-related hypophysitis, xanthomatous and necrotizing hypophysitis.

Epidemiology: incidence 1/9,000,000/year, female-to-male ratio 6:1 (lymphocytic), peak around third trimester pregnancy or postpartum; mean age 35 years for women, 45 years for men.

Pathophysiology: lymphocytic infiltration of the pituitary, anti-pituitary antibodies (anti-pit-1, anti-PRL), checkpoint inhibitor cancer therapy emerging as a major cause (anti-CTLA-4 in 5–18% of patients).

Symptoms

Headache (40–80%): often retro-orbital or frontal, may be severe
Visual disturbances: bitemporal hemianopia, visual acuity loss, ophthalmoplegia (cavernous sinus involvement)
Hypopituitarism: ACTH deficiency (50–80%, life-threatening if untreated), TSH deficiency (40–80%), gonadotropin deficiency (30–60%), GH deficiency (60–80%), prolactin abnormalities
Diabetes insipidus (30–50% of lymphocytic infundibulo-neurohypophysitis): polyuria, polydipsia, nocturia
Postpartum amenorrhea, lactation failure, fatigue and weight changes (peripartum lymphocytic hypophysitis)
Constitutional symptoms: fatigue, weakness, anorexia, weight loss
Symptoms of adrenal crisis: hypotension, hypoglycemia, abdominal pain, vomiting (medical emergency)
Hyponatremia, hyperprolactinemia (stalk effect)
IgG4-related hypophysitis: associated systemic features (autoimmune pancreatitis, sialadenitis, retroperitoneal fibrosis)

Risk Factors

Female sex (6:1 lymphocytic hypophysitis ratio)
Pregnancy and immediate postpartum period (third trimester to 6 months postpartum)
Other autoimmune disease (thyroiditis, type 1 diabetes, Addison disease, vitiligo)
Immune checkpoint inhibitor therapy: anti-CTLA-4 (ipilimumab) more often, anti-PD-1/PD-L1 less often
Family history of autoimmune disease
HLA-DR4, HLA-DR5 alleles (genetic susceptibility)
IgG4-related disease (multi-organ involvement)
Recent viral or systemic illness (rare association)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New severe headache, especially with visual disturbances
  • Symptoms of adrenal insufficiency: severe fatigue, hypotension, hypoglycemia, salt craving
  • Polyuria and polydipsia (>3 L/day) suggesting diabetes insipidus
  • Postpartum failure to lactate, persistent amenorrhea or fatigue
  • Visual field defects, ophthalmoplegia or sudden vision loss
  • Pituitary mass detected on imaging during evaluation of headache or hormonal symptoms
  • Receiving immune checkpoint inhibitor therapy with new symptoms (urgent endocrine evaluation)
  • Suspected adrenal crisis (life-threatening, requires immediate hospitalization)

Treatment Methods

01
Diagnostic workup: comprehensive pituitary hormone panel (ACTH, cortisol, TSH, free T4, FSH, LH, estradiol/testosterone, prolactin, GH, IGF-1), serum electrolytes, urine osmolality
02
Pituitary MRI with gadolinium: characteristic features include symmetric enlargement of pituitary and stalk, homogeneous enhancement, loss of posterior pituitary bright spot (in infundibulo-neurohypophysitis), suprasellar extension
03
Differential diagnosis: pituitary adenoma (asymmetric, hormone-secreting), Rathke cleft cyst, craniopharyngioma, metastasis, lymphoma, sarcoidosis, tuberculosis, Langerhans cell histiocytosis
04
Antibody testing: anti-pit-1, anti-PRL, antithyroid antibodies, IgG4 levels for IgG4-related hypophysitis
05
Pituitary biopsy: definitive diagnosis but invasive; reserved for atypical cases or therapy-refractory disease
06
Acute adrenal crisis treatment: immediate hydrocortisone 100 mg IV bolus then 50 mg every 6 hours, IV fluid resuscitation, treatment of triggering factor
07
Hormone replacement: hydrocortisone 15–25 mg/day in divided doses (cortisol replacement, stress doses for illness/surgery), levothyroxine for TSH deficiency, sex hormones for hypogonadism, growth hormone replacement for GH deficiency
08
Diabetes insipidus management: desmopressin (DDAVP) intranasal 10–20 μg twice daily or oral 0.1–0.4 mg twice daily, adjusted to symptoms and serum sodium
09
First-line immunosuppressive therapy: corticosteroids — prednisolone 0.5–1 mg/kg/day (40–60 mg) for 4–6 weeks, then taper over 3–6 months; mass shrinkage in 50–80%
10
High-dose IV methylprednisolone (1 g/day for 3–5 days) for severe disease with visual loss or rapid progression
11
Steroid-sparing therapy: azathioprine, methotrexate or mycophenolate mofetil for refractory or recurrent disease; reduces relapse risk
12
Rituximab: anti-CD20 monoclonal antibody for severe refractory disease, especially IgG4-related hypophysitis
13
Checkpoint inhibitor-induced hypophysitis: hold or reduce immunotherapy, high-dose corticosteroids (1 mg/kg/day), permanent hormone replacement (most cases); often able to resume cancer immunotherapy after stabilization
14
Surgical decompression: transsphenoidal surgery for severe mass effect, visual loss not responsive to corticosteroids, or diagnostic uncertainty
15
Radiotherapy: rarely used; reserved for refractory cases with persistent mass
16
Pregnancy considerations: corticosteroid therapy safe; close hormone monitoring, levothyroxine dose adjustment, avoid teratogenic agents
17
Long-term monitoring: serial MRI every 3–6 months initially, then annually; hormone levels every 3 months for first year, then twice yearly; relapse rate 11–25%
18
Patient education: medical alert identification, sick-day rules for stress doses (double cortisol dose for illness), recognition of adrenal crisis warning signs
19
Prognosis: hormone deficits often persistent (>50%); mass shrinkage with corticosteroids in most cases; quality of life largely preserved with proper hormone replacement
20
Multidisciplinary follow-up: endocrinology, neuro-ophthalmology, neurosurgery (if needed), oncology (for checkpoint inhibitor cases), gynecology/obstetrics for pregnancy planning

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.